Zealand Pharma A/S / Fundamentals

    Income statement

    Net revenue
    €1.22B
    Cost of goods sold
    -€722.59K
    Gross profit
    €1.22B
    SG&A expenses
    €38.33M
    R&D expenses
    €170.29M
    EBITDA
    €973.97M
    D&A
    €3.30M
    EBIT
    €961.67M
    Interest expenses
    €4.97M
    EBT
    €965.98M
    Tax expenses
    €71.50M
    Net income
    €894.49M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €119.28M
    Changes in working capital
    -€20.74M
    Operating cash flow
    €1.01B
    Capex
    €2.55M
    Other investing cash flow
    -€631.81K
    Net investing cash flow
    -€929.66M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €4.80M
    Debt repayment
    €0.00
    Other financing cash flow
    -€2.68M
    Net financing cash flow
    -€78.64M
    Foreign exchange effects
    -€22.58M
    Net change in cash
    -€21.02M
    Cash at end of period
    €969.88M
    Free cash flow
    €1.01B

    Balance sheet

    Cash and cash equivalents
    €969.88M
    Cash and short-term investments
    €2.22B
    Total receivables
    €24.42M
    Inventory
    €1.38M
    Other current assets
    €32.71M
    Total current assets
    €2.28B
    Property, plant & equipment
    €17.96M
    Goodwill
    €0.00
    Intangible assets
    €1.82M
    Long-term investments
    €0.00
    Other non-current assets
    €2.21M
    Total non-current assets
    €22.11M
    Total assets
    €2.30B
    Accounts payable
    €41.81M
    Short-term debt
    €4.68M
    Other current liabilities
    €32.70M
    Total current liabilities
    €150.95M
    Long-term debt
    €50.80M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €6.93M
    Total non-current liabilities
    €59.42M
    Total liabilities
    €210.37M
    Common stock
    €9.55M
    Retained earnings
    €107.54M
    Other equity
    €3.10M
    Total equity
    €2.09B
    Total liabilities and shareholders' equity
    €2.30B

    Company information

    Market capitalization
    €3.56B
    Employees
    385
    Enterprise Value
    €33.40B

    Company ratios

    Gross margin
    100.1% Much better than peer group: 53.2%
    EBITDA margin
    79.9% Much better than peer group: 8.3%
    EBIT margin
    78.8% Much better than peer group: 3.3%
    EBT margin
    79.2% Much better than peer group: 2.6%
    Net margin
    73.3% Much better than peer group: -7.8%
    ROE
    42.8% Much better than peer group: 2.2%
    ROA
    38.9% Much better than peer group: 2.7%
    Asset turnover
    53.0% Worse than peer group: 60.1%
    FCF margin
    82.6% Much better than peer group: -8.7%
    FCF yield
    28.3%
    Efficiency ratio
    20.1%
    Net sales per employee
    €3.17M
    Net income per employee
    €2.32M

    Notifications